The PFF Scholars program focuses on engaging early-career investigators in their emerging research in the field of pulmonary fibrosis. With the goal of advancing research that could translate into successful therapies for PF, the PFF Scholars program is designed to support and enable promising researchers to obtain independent funding and continue their cutting- edge research. Scholars will receive up to $50,000 over a two-year period.
Jeremy Katzen, MD
Title : Jeremy Katzen, MD
First Name : Jeremy
Middle Name :
Last Name : Katzen
University : Trustees of the University of Pennsylvania
Proposal Title :
Proposal Funder : Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. Katzen is a Postdoctoral Research Fellow in the Division of Pulmonary and Critical Care Medicine at the University of Pennsylvania. After completing his clinical fellowship at the Hospital of the University of Pennsylvania, he joined Dr. Michael Beers’ laboratory, where he has studied quality control dysfunction in the distal lung epithelium as it relates to diffuse parenchymal lung disease and pulmonary fibrosis. Specifically, he has modeled mutations in SFTPC to drive dysfunctional epithelial cellular phenotypes and studied the pathways from epithelial dysfunction to lung fibrosis. Prior to coming to Penn Dr. Katzen completed his internal medicine training Northwestern University, where he did research in lung epithelial host-defense in Dr. Iasha Sznajder’s laboratory. He completed his medical training at the University of Rochester School or Medicine and Dentistry and his undergraduate education at Bowdoin College. Clinically, Dr. Katzen specializes in the management of interstitial lung diseases, and he is an Attending Physician in the University of Pennsylvania Interstitial Lung Disease Clinic.